- Publication Number: 124
- Session: Parallel 19: Pediatric and Metabolic Liver Diseases: Basic and Translational
- Session Date and Time: November 13, 2016 from 4:45 PM to 6:15 PM
- Authors: Christine Wooddell, et al.
- Publication Number: LB-24
- Session: Late-Breaking Poster Session
- Session Date and Time: November 13, 2016 from 8:00 AM to 5:30 PM
- Authors: Alice Turner, et al.
For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company's email list and receive news directly, please visit http://ir.arrowheadpharma.com/alerts.cfm.Safe Harbor Statement under the Private Securities Litigation Reform Act: This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including our ability to finance our operations, the future success of our scientific studies, our ability to successfully develop drug candidates, the timing for starting and completing clinical trials, rapid technological change in our markets, and the enforcement of our intellectual property rights. Our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q discuss some of the important risk factors that may affect our business, results of operations and financial condition. We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances. DYNAMIC POLYCONJUGATES is a trademark of Arrowhead Pharmaceuticals, Inc. Source: Arrowhead Pharmaceuticals, Inc.